Xconomy: Aduro BioTech News, Articles and Opinions

“aduro-biotech” Archives

Entry	Author	Date	Location
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More	Frank Vinluan	04/26/19	National
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More	Frank Vinluan	02/01/19	National
Aduro Biotech Slashes Staff 37%, Turns Focus to Lead Cancer Drugs	Frank Vinluan	01/30/19	San Francisco
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More	Frank Vinluan	10/05/18	National
Tempest Therapeutics Debuts with $70M to Bring Cancer Drugs to Clinic	Frank Vinluan	03/28/18	San Francisco
Bio Roundup: Tax Cuts, a Funding Rush, Hemophilia Questions & More	Alex Lash	12/15/17	National
Advaxis Inks Deal with Sellas to Develop New Cancer Immunotherapy	Frank Vinluan	02/27/17	New York
Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer	Frank Vinluan	11/16/16	Indiana
Safety Issue Triggers Partial FDA Hold for Aduro Bio	Ben Fidler	10/24/16	San Francisco
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches	Alex Lash	09/07/16	National
The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More	Alex Lash	05/20/16	National
Aduro Takes Hit On Pancreatic Cancer Trial Miss, But Shares Rebound	Alex Lash	05/16/16	San Francisco
Aduro Lands New Berkeley Life Sciences Digs, with Room to Grow	Bernadette Tansey	09/18/15	San Francisco
West Coast Biotech Roundup: CRISPR, Doudna, Aduro, Amgen, NEA & More	Alex Lash	04/16/15	San Francisco
Aduro BioTech Obtains $119,000,000 New Funding	VentureDeal	04/15/15	San Francisco
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor	Alex Lash	04/14/15	National
West Coast Biotech Roundup: Auspex, Hyperion, NuVasive, & More	Bruce V. Bigelow	04/02/15	San Diego
Novartis Bets $250M-Plus on Aduro’s Immuno-Oncology Work	Bernadette Tansey	03/30/15	San Francisco
West Coast Biotech Roundup: Apple, 23andMe, Amgen, Acadia & More	Alex Lash	03/13/15	San Francisco
West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More	Alex Lash	01/08/15	San Francisco
One Week Into The New Year, Five Biotechs Reel in $220M Venture Cash	Alex Lash	01/08/15	National
West Coast Biotech Roundup: IPOs, Gilead, Sofinnova, & Denouements	Bruce V. Bigelow	07/25/14	San Diego
West Coast Biotech Roundup: Burrill, Topol, Aduro, Receptos, & More	Alex Lash	06/19/14	San Francisco
With J&J Deals, Aduro’s Cancer Vaccines Have New Chance To Prove Worth	Bernadette Tansey	06/18/14	San Francisco
Aduro BioTech Garners $55,000,000 Series C Funding Round	VentureDeal	06/12/14	San Francisco
Aduro BioTech Secures $6,500,000 New Financing	VentureDeal	01/31/13	San Francisco
Aduro BioTech Secures $19,250,000 Series B Funding Round	VentureDeal	04/20/11	San Francisco
Page 1 of 1